Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets
NHS hospitals in England used £51,059,872 of indicative cost of Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 3.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Chelsea & Westminster Hospital Nhs Ft | £10,147,536 |
| Manchester University Nhs Ft | £5,309,546 |
| Guy's & St Thomas' Nhs Foundation Trust | £3,073,913 |
| Western Sussex Hospitals Nhs Found Trust | £2,621,989 |
| Imperial College Healthcare Nhs Trust | £2,573,390 |
| University College London Foundation Tr | £2,117,724 |
| Leeds Teaching Hpls Nhs Trust | £2,085,673 |
| Ctrl & N W London Nhs Foundation Trust | £1,733,991 |
| Royal Free London Nhs Foundation Trust | £1,617,510 |
| Aintree University Hospital Nhs Ft | £1,493,816 |
The primary-care picture
Doravirine is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Doravirine medicine page.